Up and Coming
This feature highlights changes in clinical trial organizations’ personnel.
Thorsten Graef has been named chief medical officer of biotechnology company Acepodia. Previously, Graef was vice president of oncology and early development at AbbVie.
Mark Timney has taken the helm of Attralus Therapeutics as its newest CEO. Previously, Timney was CEO of the Medicines Company. Attralus has also hired Gregory Bell as the company’s new chief medical officer. Bell most recently served as senior vice president of development and chief medical officer at KAI Pharmaceuticals. Michael Klein, former vice president of analytical development at Nektar Therapeutics, was also recently appointed by Attralus to head of chemistry, manufacturing and controls.
aTyr Pharma has promoted Leslie Nangle from senior director of research to vice president of research.
Swati Tole, former vice president of clinical development at Genentech, has been named the new chief medical officer at Capsida Biotherapeutics.
Antoine Yver, former executive vice president and global head of R&D oncology at Daiichi Sankyo, has been named the new chief medical officer at Centessa Pharmaceuticals.
Jennifer Wheler has been named chief medical officer at Codiak BioSciences. Wheler is the former chief medical officer of Bicara Therapeutics.
Cyclo Therapeutics has hired Lori Gorski as global head of patient advocacy. Gorski previously served as senior director of public affairs and advocacy at Radius Health.
Drug Farm has hired Jeysen Yogaratnam to take on the role of chief medical officer. Yogaratnam previously served as senior medical director of Aligos Therapeutics.
Roger Perlmutter has taken over Eikon Therapeutics as its newest CEO. Perlmutter was formerly the executive vice president of Merck.
Essential Pharma has named Steen Vangsgaard CEO of the company. Vangsgaard most recently served as senior vice president and general manager of Europe/Rest of World at Covis Pharma.
Fulcrum Therapeutics has appointed Christopher Morabito to chief medical officer. Previously, Morabito served as chief medical officer at Cardurion Pharmaceuticals.
Guardant Health has appointed Craig Eagle to chief medical officer. Previously, Eagle served as vice president of medical affairs oncology at Genentech.
Jaguar Gene Therapy
Joe McIntosh has taken on the chief medical officer role at Jaguar Gene Therapy. Most recently, McIntosh was chief medical officer at Aruvant.
Yizhe Wang has taken over LianBio as its newest CEO. Wang was formerly the global brand development leader of Lilly Oncology at Eli Lilly.
Erin Foff, former executive director of clinical development at Acadia Pharmaceuticals, has been named the new chief medical officer at MapLight Therapeutics.
John Lord has been named the new vice president of research and development at Maxwell Biosciences. Lord was previously the head of research and development at Savara.
Mann Muhsin has been named chief medical officer of Medicenna Therapeutics. Muhsin is the former medical lead of oncology clinical development at Nektar Therapeutics.
Metrics Contract Services
Metrics Contract Services has appointed Stephanie Emory to associate director of pharmaceutical development. Previously, Emory served as chemist and drug product reviewer at the FDA.
William Kassler, formerly IBM Watson Health’s deputy chief health officer and chief medical officer, has been named the new chief medical officer at Palantir Technologies.
Relay Therapeutics has appointed Charles Ferté to vice president and global medical lead. Ferté previously served as senior director and global project leader at AstraZeneca.
Baltazar Gomez-Mancilla, former executive director of neuroscience and translation of medicine at Novartis, has been named the new chief medical officer at Stalicla.
Strike Pharma has appointed Mårten Winge to CEO of the company. Winge previously served as CEO of Cartana.